Tenax Therapeutics Statistics Share Statistics Tenax Therapeutics has 4.15M
shares outstanding. The number of shares has increased by 21.7%
in one year.
Shares Outstanding 4.15M Shares Change (YoY) 21.7% Shares Change (QoQ) 4.49% Owned by Institutions (%) 5.48% Shares Floating 3.63M Failed to Deliver (FTD) Shares 223 FTD / Avg. Volume 0.88%
Short Selling Information The latest short interest is 336.44K, so 8.11% of the outstanding
shares have been sold short.
Short Interest 336.44K Short % of Shares Out 8.11% Short % of Float 8.38% Short Ratio (days to cover) 39.25
Valuation Ratios The PE ratio is -5.37 and the forward
PE ratio is -2.08.
Tenax Therapeutics's PEG ratio is
0.06.
PE Ratio -5.37 Forward PE -2.08 PS Ratio 0 Forward PS 5.8 PB Ratio 1.03 P/FCF Ratio -6.38 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tenax Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.6,
with a Debt / Equity ratio of 0.
Current Ratio 20.6 Quick Ratio 20.6 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -847.57
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.4M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 61.77% in the
last 52 weeks. The beta is 1.46, so Tenax Therapeutics's
price volatility has been higher than the market average.
Beta 1.46 52-Week Price Change 61.77% 50-Day Moving Average 5.93 200-Day Moving Average 5.86 Relative Strength Index (RSI) 43.46 Average Volume (20 Days) 25,211
Income Statement
Revenue n/a Gross Profit n/a Operating Income -19.49M Net Income -17.6M EBITDA -17.58M EBIT -17.63M Earnings Per Share (EPS) -1.15
Full Income Statement Balance Sheet The company has 94.85M in cash and 0 in
debt, giving a net cash position of 94.85M.
Cash & Cash Equivalents 94.85M Total Debt n/a Net Cash n/a Retained Earnings -314.86M Total Assets 112.06M Working Capital 109.29M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.81M
and capital expenditures 0, giving a free cash flow of -14.81M.
Operating Cash Flow -14.81M Capital Expenditures n/a Free Cash Flow -14.81M FCF Per Share -0.97
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TENX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TENX is $16,
which is 174% higher than the current price. The consensus rating is "Buy".
Price Target $16 Price Target Difference 174% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 3, 2024. It was a
backward
split with a ratio of 1:80.
Last Split Date Jan 3, 2024 Split Type backward Split Ratio 1:80
Scores Altman Z-Score 2.01 Piotroski F-Score 2
